EUVIMEDEUVIMED entdecken
Crossref

Enhanced NIR-triggered photo-to-chemo conversion based on plasmonic heterojunction nanozyme for tetra-hybrid antineoplastic therapy

Yunxiang Zhang, Derui Xu, Xiaohui Wang, Hongsheng Shen, Bin Chen, Qian Liu, Yating Cui, Xinmiao Hou, Siyu Zhao, Qing Song, Xichuan Li, Xinghua Jin

Chemical Engineering Journal · 2025-04 · 509 · 161306

DOI: 10.1016/j.cej.2025.161306 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Engineering Journal, 2025-04. Verfasst von Yunxiang Zhang und 11 weiteren Autor:innen. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 115 Literaturangaben. Gefördert von: School of Life Sciences and Biotechnology Division of Life Sciences, Korea University, Tianjin Normal University, Tianjin Municipal Bureau of Public Health.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • School of Life Sciences and Biotechnology Division of Life Sciences, Korea University
  • Tianjin Normal University
  • Tianjin Municipal Bureau of Public Health
  • Tianjin University

Zitieren

APA

Zhang, Y., Xu, D., Wang, X., Shen, H., Chen, B., Liu, Q., Cui, Y., Hou, X., Zhao, S., Song, Q., Li, X., & Jin, X. (2025). Enhanced NIR-triggered photo-to-chemo conversion based on plasmonic heterojunction nanozyme for tetra-hybrid antineoplastic therapy. Chemical Engineering Journal, 509, 161306. https://doi.org/10.1016/j.cej.2025.161306

Vancouver

Zhang Y, Xu D, Wang X, Shen H, Chen B, Liu Q, et al. Enhanced NIR-triggered photo-to-chemo conversion based on plasmonic heterojunction nanozyme for tetra-hybrid antineoplastic therapy. Chemical Engineering Journal. 2025;509:161306. doi:10.1016/j.cej.2025.161306

BibTeX
@article{Zhang2025,
  author = {Zhang, Yunxiang and Xu, Derui and Wang, Xiaohui and Shen, Hongsheng and Chen, Bin and Liu, Qian and Cui, Yating and Hou, Xinmiao and Zhao, Siyu and Song, Qing and Li, Xichuan and Jin, Xinghua},
  title = {Enhanced NIR-triggered photo-to-chemo conversion based on plasmonic heterojunction nanozyme for tetra-hybrid antineoplastic therapy},
  journal = {Chemical Engineering Journal},
  year = {2025},
  volume = {509},
  pages = {161306},
  doi = {10.1016/j.cej.2025.161306}
}
Kostenlos starten →